Meeting Coverage
HFSA
Heart Failure Society of America
Latest HFSA Meeting Coverage
Cardiac myosin inhibitor linked to improvements in biomarkers in small study
Vast majority of trial participants responded to aficamten
Benefit of the nonsteroidal MRA otherwise consistent across FINEARTS-HF
Splanchnic nerve ablation for volume management passes a feasibility hurdle
Early-phase study analysis suggests potential for remodeling
STRONG-HF analysis details the impact
Autonomic regulation therapy trial showed signal for benefit in terminated pivotal trial
GUIDE-HF trial analysis distinguishes "strata" with different levels of risk
Decision cites insufficient evidence of clinical meaningfulness
STEP-HFpEF trial results come out consistent across ejection fraction
Small randomized trial challenges conventional thinking about sodium
Heart pump placement plus anticoagulation suffice for patients, even those with Afib
Transplant surgeons discuss testing the concept in more humans
Analyses continue to support wider adoption of dapagliflozin, researchers say
Latest Cardiology Meeting Coverage
-
TCT: Transcatheter Cardiovascular Therapeutics
October 2024
-
HFSA: Heart Failure Society of America
September 2024
-
ESC: European Society of Cardiology Congress
August 2024
-
TVT: Transcatheter Valve Therapy
June 2024